Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenic effects of alpha-synuclein aggregation.

Ditte Lundvig1, Evo Lindersson, Poul Henning Jensen

  • 1Department of Medical Biochemistry, University of Aarhus, Building 170, Ole Worms Alle 170, DK-8000, Aarchus, Denmark.

Brain Research. Molecular Brain Research
|March 26, 2005
PubMed
Summary

Alpha-synuclein aggregation is central to neurodegenerative diseases like Parkinson's. This review explores how these protein aggregates disrupt cellular functions and the factors influencing their formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeing Invisible Oligomers: Rethinking α-Synuclein Pathology Through Proximity Ligation Assay.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Higher-molecular-weight a-synuclein oligomers are increased in the brain cytosol of patients with dementia with Lewy bodies.

NPJ Parkinson's disease·2026
Same author

Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.

NPJ Parkinson's disease·2025
Same author

Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.

Acta neuropathologica·2025
Same author

Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei.

Acta neuropathologica communications·2025
Same author

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.

NPJ Parkinson's disease·2024

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Alpha-synuclein aggregation is implicated in Parkinson's disease, multiple system atrophy, and Lewy body dementia.
  • Understanding the role of alpha-synuclein in neurodegeneration is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent data on the impact of alpha-synuclein aggregates on cellular homeostatic mechanisms.
  • To discuss the different molecular species of alpha-synuclein aggregates and factors influencing their formation.

Main Methods:

  • Literature review of biochemical and genetic evidence.
  • Analysis of studies on cellular transport, degradation, and transcriptional regulation.
  • Discussion of methodologies for studying alpha-synuclein aggregates.

Related Experiment Videos

Main Results:

  • Alpha-synuclein aggregates significantly impact cellular transport, degradation, and transcriptional regulation.
  • Diverse molecular species of alpha-synuclein aggregates exist, each with distinct features.
  • Various chemical and physical factors influence the formation and characteristics of these aggregates.

Conclusions:

  • Alpha-synuclein aggregation is a key factor in neurodegenerative disease pathogenesis.
  • Further research into the diverse species and formation factors of alpha-synuclein aggregates is warranted.
  • Targeting alpha-synuclein aggregation pathways may offer therapeutic strategies for neurodegenerative disorders.